Top 5 Most-Watched Interviews in 2019
In 2019, The American Journal of Managed Care® team interviewed key opinion leaders nationwide. Here are the top 5 most-watched interviews from this year.
Related Articles
Guselkumab Clears Scalp Psoriasis Across All Skin Tones
A new trial finds guselkumab is highly effective and well tolerated for moderate to severe scalp psoriasis in individuals with diverse skin tones.
Medicare Inflation Rebates Show Limited Impact on Drug Price Trends
Medicare inflation rebates fail to curb rising drug prices, highlighting the need for further policy action to control costs.
Crossover Study: Nanomicellar Cyclosporine 0.09% vs Emulsion Cyclosporine 0.05%
A panelist discusses how the COAT trial showed that switching patients with uncontrolled dry eye disease on cyclosporine 0.05% to the 0.09% solution led to…
American Journal of Managed Care News & Expert Insights | AJMC
The American Journal of Managed Care News section is a comprehensive resource for clinical news and expert insights. Read more at AJMC.
Current Treatment Paradigms: Efficacy, Safety, and Patient Adherence in IPF and PPF Care
Panelists discuss how effective management of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) relies on early, accurate diagnosis and multidisciplinary collaboration, with a…
Gaps in Arthritis Subtype Awareness Highlight Health Literacy Disparities Among US Adults
Significant gaps in arthritis subtype awareness among US adults underscore the need for improved health literacy and more targeted public health efforts.
Accommodations as DMD Progresses Incur Substantial Household Costs
Families caring for individuals with Duchenne muscular dystrophy (DMD) face significant financial burdens from necessary home and vehicle modifications to enhance quality of life.
RFK Jr Has Power to Remove USPSTF Members With Braidwood Decision: Jeffrey Fitzgerald, JD
The recent decision in Kennedy v Braidwood could give Robert F. Kennedy Jr, secretary of HHS, the ability to remove all members of the US…
Patients With Advanced NSCLC Face Critical Treatment Gaps
New research reveals critical gaps in treatment for advanced non–small cell lung cancer (NSCLC), emphasizing the need for innovative therapies to improve patient outcomes.
GLP-1 Receptor Agonists Show Promise as Adjunctive Treatment for Ovarian Cancer
Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, offering a promising adjunct to traditional treatments.